Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigation of the effect of rivastigmine patch on gait disturbance in patients with Alzheimer disease. Clinical study (intervention study).

Trial Profile

Investigation of the effect of rivastigmine patch on gait disturbance in patients with Alzheimer disease. Clinical study (intervention study).

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Dec 2018

At a glance

  • Drugs Rivastigmine (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jul 2018 Status changed from recruiting to active, no longer recruiting.
    • 17 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top